188k views
2 votes
When did the FDA introduce its regulations, and what did they primarily entail?

a) 1940s, focusing on drug safety and efficacy
b) 1980s, emphasizing dietary supplements regulations
c) 1960s, concentrating on medical device manufacturing
d) 2000s, stressing drug affordability and accessibility

User Kbpontius
by
7.5k points

1 Answer

3 votes

Final answer:

The FDA's regulations were introduced in the 1940s, focusing on drug safety and efficacy. These regulations have evolved to cover a wide array of products and services, with the FDA ensuring that medicines must undergo extensive testing before reaching the market. While such regulations protect consumers, they can delay access to new treatments and impose high costs on pharmaceutical companies.

Step-by-step explanation:

When did the FDA introduce its regulations, and what did they primarily entail? The correct answer is a) 1940s, focusing on drug safety and efficacy. The Federal Food, Drug, and Cosmetic Act was first passed in 1938 and has been extensively amended since. It serves as the basis for the FDA's regulatory authority, which includes ensuring that medicines are safe and effective before they are sold in pharmacies - a process that often requires years of testing. Evolution of the FDA: Initially, under the Pure Food and Drug Act, the FDA was responsible for ensuring the safety and proper labeling of foods, drugs, and cosmetics. Over time, its role has evolved to encompass a vast range of products and services, including dietary supplements, medical devices, and the oversight of product manufacturing processes. For example, the regulation of dietary supplements, mentioned as an option in the question, was emphasized in the 1980s under the Dietary Supplement Health and Education Act of 1994. While the FDA's regulations are designed to protect consumers, they can also create challenges. One group that faces difficulties are the 'anonymous losers' who do not benefit from these stringent regulations. These can include patients who desperately need access to new therapies that may be delayed due to the lengthy approval process, and the pharmaceutical companies who must bear the significant costs of testing and compliance.

User Teepark
by
7.5k points